MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.
From co-founders Lewis S. Blevins Jr., MD and JD Faccinetti – Today we wanted to take a break from our regular publishing and write a few lines to mention some important things. Pituitary World News
Pregnancy Could Be Linked to Onset of Cushing’s Symptoms, a Retrospective Study From CATARINA SILVA for Cushing’s Disease News – More than 25 percent of women with Cushing’s disease experienced their first symptoms within one year of giving birth,
From the desk of J D Faccinetti, co-founder – Many new wonderful friends, new perspectives and a ton of energy dedicated to increase awareness and reduce the time to diagnosis; that’s the best way I
From the desk of JD Faccinetti co-founder – On behalf of Dr. Lewis Blevins and myself, a big thank you to Engage Health for recognizing Pituitary World News as a Rare Disease Difference Maker™. The program recognizes individuals who
Listen to a discussion of Acromegaly cases that, for a variety of clinical and biochemical reasons, are difficult to discern. Learn about people with definite acromegaly but negative MRI studies. Why are some microadenomas
Each year, the University of California, San Francisco graduates four neurosurgical residents who have met the basic qualifications to become practicing neurosurgeons. Most, however, go on to additional training to subspecialize in the field of
We recently did a survey to explore opinions and attitudes about laboratory testing prior to a visit with your doctor. The reason: patients are increasingly requesting laboratory tests results be obtained in advance of their
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, announced recently it has launched a new fund to provide copayment and premium assistance to Medicare patients living with acromegaly.
From J D Faccinetti – cofounder. It is fun to think about complicated subjects particularly when those subjects include technology, medicine, and the mobile internet. As you ponder about change and what it means, it’s
From Linda M. Rio, Marriage & Family Therapist: Hurricanes of biblical proportion, a mass shooting to defy all imagination, not to mention fires out West and the innumerable daily, “normal” deaths and destruction all amount
When it comes to pituitary information on the web, not all guides are created equal. We did some research on the best web-based “Pituitary tumor: Frequently Asked Questions”, (FAQ). Here’s what we found: For an
From Jorge D Faccinetti, cofounder – Surgery has a way of giving you time to think about things you typically don’t think about. Such was the case with me these last 3 weeks. After a